J&J OTC Brands Regain Market Share
This article was originally published in The Tan Sheet
Executive Summary
Evidence of J&J’s U.S. OTC sales turnaround includes Children’s Tylenol, Children’s Motrin and Zyrtec as top sellers behind private label products in their categories and Tylenol sales growing more than 20% during the 12 weeks ending June 16, according to market research firm IRI’s data.